NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
79 hedge funds and large institutions have $90.3M invested in Navidea Biopharmaceuticals Inc. in 2013 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 32 increasing their positions, 20 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $87.1M → $90.3M (+$3.18M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
79
Holding in Top 10
1
Calls
$4.87M
Puts
$1.47M
Top Buyers
| 1 | +$3.7M | |
| 2 | +$1.82M | |
| 3 | +$1.03M | |
| 4 |
PM
Platinum Management
New York
|
+$442K |
| 5 |
State Street
Boston,
Massachusetts
|
+$337K |
Top Sellers
| 1 | -$2.32M | |
| 2 | -$1.14M | |
| 3 | -$590K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$329K |
| 5 |
FAAS
First Allied Advisory Services
San Diego,
California
|
-$164K |